Strata Skin Sciences, Inc.
SSKN
$2.20
-$0.0636-2.81%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 3.30% | 0.61% | -7.36% | -8.66% | -11.29% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.30% | 0.61% | -7.36% | -8.66% | -11.29% |
| Cost of Revenue | -9.23% | -2.79% | -1.44% | 3.31% | 5.00% |
| Gross Profit | 14.55% | 3.36% | -11.62% | -16.77% | -22.13% |
| SG&A Expenses | 3.98% | 0.55% | -3.77% | -13.31% | -12.59% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.62% | -1.82% | -3.57% | -7.69% | -5.89% |
| Operating Income | 31.75% | 14.65% | -22.99% | 1.02% | -34.29% |
| Income Before Tax | 18.64% | 6.10% | -32.83% | -18.81% | -96.86% |
| Income Tax Expenses | -84.78% | -84.78% | -246.03% | -246.03% | -246.03% |
| Earnings from Continuing Operations | 19.48% | 6.87% | -30.39% | -16.48% | -93.18% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.48% | 6.87% | -30.39% | -16.48% | -93.18% |
| EBIT | 31.75% | 14.65% | -22.99% | 1.02% | -34.29% |
| EBITDA | 134.40% | 44.46% | -306.00% | -68.99% | -378.72% |
| EPS Basic | 31.83% | 16.41% | -25.88% | -15.88% | -92.09% |
| Normalized Basic EPS | 33.25% | 11.76% | -24.29% | -12.69% | -41.18% |
| EPS Diluted | 31.83% | 16.41% | -25.88% | -15.88% | -92.09% |
| Normalized Diluted EPS | 33.25% | 11.76% | -24.29% | -12.69% | -41.18% |
| Average Basic Shares Outstanding | 13.60% | 9.00% | 4.42% | 0.62% | 0.61% |
| Average Diluted Shares Outstanding | 13.60% | 9.00% | 4.42% | 0.62% | 0.61% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |